Covered recipient · General Payments record
MAGEN ELIZABETH HEIDE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$1,289.47
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $439.99 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $157.23 | 10 |
| Novo Nordisk AS | $84.75 | 5 |
| Exact Sciences Corporation | $62.25 | 4 |
| Amgen Inc. | $43.72 | 3 |
| GlaxoSmithKline, LLC. | $33.78 | 2 |
| Astellas Pharma US Inc | $28.07 | 1 |
| DEXCOM, INC. | $15.87 | 1 |
| Currax Pharmaceuticals LLC | $14.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.38 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117274613 | CMS |
| Amgen Inc. | $16.87 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117274615 | CMS |
| Amgen Inc. | $13.47 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117274617 | CMS |
| Astellas Pharma US Inc | $28.07 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139434328 | CMS |
| Currax Pharmaceuticals LLC | $14.32 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089513000 | CMS |
| Dexcom, Inc. | $15.87 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318098 | CMS |
| Exact Sciences Corporation | $15.72 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114452849 | CMS |
| Exact Sciences Corporation | $14.67 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114452853 | CMS |
| Exact Sciences Corporation | $16.03 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114452857 | CMS |
| Exact Sciences Corporation | $15.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114452862 | CMS |
| GlaxoSmithKline, LLC. | $18.07 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116579523 | CMS |
| GlaxoSmithKline, LLC. | $15.71 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116027866 | CMS |
| Lilly USA, LLC | $13.37 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135145521 | CMS |
| Lilly USA, LLC | $15.02 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135162163 | CMS |
| Lilly USA, LLC | $14.04 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135153052 | CMS |
| Lilly USA, LLC | $16.68 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135153048 | CMS |
| Lilly USA, LLC | $13.92 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143409 | CMS |
| Lilly USA, LLC | $27.06 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100230 | CMS |
| Lilly USA, LLC | $12.62 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135139038 | CMS |
| Lilly USA, LLC | $14.05 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135161315 | CMS |
| Lilly USA, LLC | $17.75 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143407 | CMS |
| Lilly USA, LLC | $12.72 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135153050 | CMS |
| Novo Nordisk Inc | $14.47 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097619140 | CMS |
| Novo Nordisk Inc | $13.71 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097807472 | CMS |
| Novo Nordisk Inc | $23.19 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599111 | CMS |
| Novo Nordisk Inc | $13.63 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097727557 | CMS |
| Novo Nordisk Inc | $19.75 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097417636 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.